Top

Neurological Sciences

Published in:

01-08-2021 | Multiple Sclerosis | Letter to the Editor

Chronic relapsing inflammatory optic neuropathy in a patient with triple antiphospholipid antibody positivity

Authors: Cristian Eduardo Navarro, Gabriel José Arango, María F. Cubides

Published in: Neurological Sciences | Issue 8/2021

Excerpt

Dear Editor, …

Abreu MM, Danowski A, Wahl DG, Amigo MC, Tektonidou M, Pacheco MS, Fleming N, Domingues V, Sciascia S, Lyra JO, Petri M, Khamashta M, Levy RA (2015) The relevance of “non-criteria” clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on antiphospholipid syndrome clinical features. Autoimmun Rev 14:401–414. https://doi.org/10.1016/j.autrev.2015.01.002CrossRefPubMed

Zhu DS, Fu J, Zhang Y, Li SX, Zhang GX, Guan YT, Dong Q (2014) Neurological antiphospholipid syndrome: clinical, neuroimaging, and pathological characteristics. J Neurol Sci 346:138–144. https://doi.org/10.1016/j.jns.2014.08.010CrossRefPubMed

Cecchi I, Radin M, Rubini E, Foddai SG, Barinotti A, Roccatello D, Sciascia S (2021) Clinical manifestations in patients with antiphospholipid antibodies: beyond thrombosis and pregnancy loss. Lupus 0961203321:884–892. https://doi.org/10.1177/0961203321995248CrossRef

Sciascia S, Radin M, Cecchi I, Bertolaccini ML, Bertero MT, Rubini E, Vaccarino A, Bazzan M, Giachino O, Baldovino S, Rossi D, Mengozzi G, Roccatello D (2021) Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients. Rheumatology 60:1106–1113. https://doi.org/10.1093/rheumatology/kez596CrossRefPubMed

Ogino S, Iwamoto K, Yamamoto H, Yamaguchi K, Kondo M (1992) A case of optic neuritis associated with anticardiolipin antibodies. Rinsho Shinkeigaku 32:330–332PubMed

Marie I, Hervé F, Borg J, Levesque H (2007) Retrobulbar optic neuritis revealing primary anti-phospholipid antibody syndrome. Scand J Rheumatol 36:156–157. https://doi.org/10.1080/03009740701218832CrossRefPubMed

Rajasekaran D, Jayapandian P, Subbaraghavalu G (2009) Primary antiphospholipid antibody syndrome with optic neuritis. J Assoc Physicians India 57:665PubMed

Sciascia S, Amigo MC, Roccatello D, Khamashta M (2017) Diagnosing antiphospholipid syndrome: “extra-criteria” manifestations and technical advances. Nat Rev Rheumatol 13:548–560. https://doi.org/10.1038/nrrheum.2017.124CrossRefPubMed

Islam MA, Alam F, Kamal MA, Wong K, Sasongko T, Gan S (2016) “Non-criteria” neurologic manifestations of antiphospholipid syndrome: a hidden kingdom to be discovered. CNS Neurol Disord Drug Targets 15:1253–1265. https://doi.org/10.2174/1871527315666160920122750CrossRefPubMed

10.

Xourgia E, Tektonidou MG (2020) Management of non-criteria manifestations in antiphospholipid syndrome. Curr Rheumatol Rep 22:51. https://doi.org/10.1007/s11926-020-00935-2CrossRefPubMed

11.

Espinosa G, Cervera R (2015) Current treatment of antiphospholipid syndrome: lights and shadows. Nat Rev Rheumatol 11:586–596. https://doi.org/10.1038/nrrheum.2015.88CrossRefPubMed

12.

Petzold A, Plant GT (2014) Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported. J Neurol 261:17–26. https://doi.org/10.1007/s00415-013-6957-4CrossRefPubMed

13.

Jang Y, Kim S-M, Yun YI, Lee HJ, Kim SJ, Jung JH, Shin JH (2020) Comparison between optic neuritis associated with antibody against myelin oligodendrocyte glycoprotein and presumed idiopathic optic perineuritis. Neurol Sci 41:2755–2760. https://doi.org/10.1007/s10072-020-04371-zCrossRefPubMed

14.

Kidd D, Burton B, Plant GT, Graham EM (2003) Chronic relapsing inflammatory optic neuropathy (CRION). Brain 126:276–284. https://doi.org/10.1093/brain/awg045CrossRefPubMed

15.

Lee HJ, Kim B, Waters P, Woodhall M, Irani S, Ahn S, Kim SJ, Kim SM (2018) Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies. J Neuroinflammation 15:1–9. https://doi.org/10.1186/s12974-018-1335-xCrossRef

16.

Liu H, Zhou H, Wang J, Xu Q, Wei S (2019) Antibodies to myelin oligodendrocyte glycoprotein in chronic relapsing inflammatory optic neuropathy. Br J Ophthalmol 103:1423–1428. https://doi.org/10.1136/bjophthalmol-2018-313142CrossRefPubMed

17.

Tektonidou MG, Andreoli L, Limper M, Amoura Z, Cervera R, Costedoat-Chalumeau N, Cuadrado MJ, Dörner T, Ferrer-Oliveras R, Hambly K, Khamashta MA, King J, Marchiori F, Meroni PL, Mosca M, Pengo V, Raio L, Ruiz-Irastorza G, Shoenfeld Y, Stojanovich L, Svenungsson E, Wahl D, Tincani A, Ward MM (2019) EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis 78:1296–1304. https://doi.org/10.1136/annrheumdis-2019-215213CrossRefPubMed

18.

Radin M, Ugolini-Lopes MR, Sciascia S, Andrade D (2018) Extra-criteria manifestations of antiphospholipid syndrome: risk assessment and management. Semin Arthritis Rheum 48:117–120. https://doi.org/10.1016/j.semarthrit.2017.12.006CrossRefPubMed

Title: Chronic relapsing inflammatory optic neuropathy in a patient with triple antiphospholipid antibody positivity
Authors: Cristian Eduardo Navarro
Gabriel José Arango
María F. Cubides
Publication date: 01-08-2021
Publisher: Springer International Publishing
Keywords: Multiple Sclerosis
Antiphospholipid Syndrome
Optic Neuritis
Neuromyelitis Optica Spectrum Disease
Antiphospholipid Syndrome
Published in: Neurological Sciences / Issue 8/2021
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-021-05263-6

At a glance: The STEP trials

Springer Medicine

Chronic relapsing inflammatory optic neuropathy in a patient with triple antiphospholipid antibody positivity

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 8/2021

The efficacy of ultrasound-guided stellate ganglion block in alleviating postoperative pain and ventricular arrhythmias and its application prospects

Superoxide dismutase (SOD), advanced oxidation protein products (AOPP), and disease-modifying treatment are related to better relapse recovery after corticosteroid treatment in multiple sclerosis

Role of examples in contextualizing novel information: a neuroscience insight

Correction to: Unilateral freezing of gait or “magnetic feet phenomenon” caused by ischemic lesion involving fronto-striatal networks

Association between MMP16 rs60298754 and clinical phenotypes of Parkinson’s disease in southern Chinese

Why is delirium more frequent in the elderly?